Al-Mohammad Abdallah, Partridge David G, Fent Graham, Watson Oliver, Lewis Nigel T, Storey Robert F, Makris Michael, Chico Timothy J
Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Vasc Biol. 2020 Oct 20;2(1):R105-R114. doi: 10.1530/VB-20-0009. eCollection 2020.
Since the first description of COVID-19 in December 2019, more than 63,000 publications have described its virology, clinical course, management, treatment and prevention. Most physicians are now encountering, or will soon encounter, patients with COVID-19 and must attempt to simultaneously assimilate this avalanche of information while managing an entirely novel disease with few guiding precedents. It is increasingly clear that, although primarily a respiratory illness, COVID-19 is associated with cardiovascular complications. However, the true incidence of direct cardiac complications remains unclear, as all complications thus far reported can also occur in patients without COVID-19. In this review, we briefly summarise and critically appraise the data on cardiac complications associated with COVID-19 and describe some cases from our own experience. We identify unresolved questions and highlight the many uncertainties in this developing field.
自2019年12月首次描述新型冠状病毒肺炎（COVID-19）以来，已有超过63000篇出版物描述了其病毒学、临床病程、管理、治疗和预防。现在，大多数医生正在接诊或即将接诊COVID-19患者，并且必须在管理一种几乎没有指导先例的全新疾病的同时，试图同步吸收这大量的信息。越来越明显的是，尽管COVID-19主要是一种呼吸系统疾病，但它与心血管并发症有关。然而，直接心脏并发症的真实发病率仍不清楚，因为迄今为止报道的所有并发症也可能发生在没有COVID-19的患者中。在这篇综述中，我们简要总结并批判性地评估了与COVID-19相关的心脏并发症的数据，并描述了我们自己经验中的一些病例。我们确定了尚未解决的问题，并强调了这个不断发展的领域中的许多不确定性。
